Hopp til innhold

Get alerts of updates about «Plasma concentrations of poly- and perfluoroalkyl substances (PFASs) in pregnant women and the association with child's prenatal and postnatal growth.»

How often would you like to receive alerts from fhi.no? (This affects all your alerts)
Do you also want alerts about:

The email address you register will only be used to send you these alerts. You can cancel your alerts and delete your email address at any time by following the link in the alerts you receive.
Read more about the privacy policy for fhi.no

You have subscribed to alerts about:

  • Plasma concentrations of poly- and perfluoroalkyl substances (PFASs) in pregnant women and the association with child's prenatal and postnatal growth.

Project

Plasma concentrations of poly- and perfluoroalkyl substances (PFASs) in pregnant women and the association with child's prenatal and postnatal growth. - project description

Published Updated

We will investigate how exposure to PFAS during pregnancy can affect fetal growth within a large meta-analysis of European birth cohorts.


Summary

High exposure to pollutants in vulnerable life stages, especially in fetal life can adversely affect the fetus and “program” disease later in life. Poly- and perfluoroalkyl substances (PFASs) make up a large group of persistent anthropogenic chemicals used in industrial processes and commercial products over the past 60 years. PFAS are found in blood samples of Norwegian pregnant women. By using existing data from the Norwegian mother and child cohort study we will investigate how exposure to PFAS during pregnancy can affect fetal growth within a large meta-analysis of European birth cohorts. Further, we will provide knowledge on how exposure to PFAS in pregnancy can affect growth, weight development and metabolic disturbances in Norwegian children. Finally we will explore if the PFAS levels of the pregnant women are clustered in specific geographical areas around the country.  

See the full project description at Cristin for more information about results, researchers, contact information etc.

Project participants

Project leader

Line Småstuen Haug, Norwegian Institute of Public Health

Project participants

Line Småstuen Haug, Infection Control, Norwegian Institute of Public Health
Helle Margrete Meltzer, Infection Control, Norwegian Institute of Public Health
Gro Dehli Villanger, Norwegian Institute of Public Health
Heidi Aase, Norwegian Institute of Public Health
Thorhallur Ingi Halldórsson, University of Iceland
Cathrine Thomsen, Norwegian Institute of Public Health
Eleni Zoumpoulia Papadopoulou, Norwegian Institute of Public Health

Start

01.03.2018

End

01.02.2024

Status

Active

Approvals

Regional committees for medical and health research ethics

Project owner/ Project manager

Norwegian Institute of Public Health

Project manager

Line Småstuen Haug